Literature DB >> 1834364

Second European Consensus Document on chronic critical leg ischemia.

.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1834364

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  26 in total

1.  Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment.

Authors:  Daniel Mathieu; Alessandro Marroni; Jacek Kot
Journal:  Diving Hyperb Med       Date:  2017-03       Impact factor: 0.887

2.  Critical leg ischaemia in New Zealand: economic cost of amputation versus intravenous iloprost.

Authors:  H M Scott; W G Scott
Journal:  Pharmacoeconomics       Date:  1994-08       Impact factor: 4.981

Review 3.  Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.

Authors:  L B Barradell; R N Brogden
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

4.  Further evidence for a role of endothelin-1 (ET-1) in critical limb ischaemia.

Authors:  Michael Richard Dashwood; Janice C S Tsui
Journal:  J Cell Commun Signal       Date:  2010-11-27       Impact factor: 5.782

5.  Maggot debridement therapy of infected ulcers: patient and wound factors influencing outcome - a study on 101 patients with 117 wounds.

Authors:  Pascal Steenvoorde; Cathrien E Jacobi; Louk Van Doorn; Jacques Oskam
Journal:  Ann R Coll Surg Engl       Date:  2007-09       Impact factor: 1.891

6.  Iloprost antagonizes the increase in internal calcium concentration induced by alpha-thrombin in human platelets: a study of desensitization.

Authors:  E Cecchi; L Capone; C Ruocco; A Fazzini; A Mugelli; A Giotti; P Failli
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

Review 7.  [Diagnostic and therapeutic stragegies in peripheral obliterative arteriopathy: non-drug treatment].

Authors:  J N Fiessinger
Journal:  Drugs       Date:  1998       Impact factor: 9.546

Review 8.  [Drug treatment strategies for peripheral obliterative arteriopathy].

Authors:  H Bounameaux; R Wütschert
Journal:  Drugs       Date:  1998       Impact factor: 9.546

Review 9.  [Epidemiology and prognosis of peripheral obliterative arteriopathy].

Authors:  R Verhaeghe
Journal:  Drugs       Date:  1998       Impact factor: 9.546

10.  [Therapy of chronic ischemic pain in peripheral arterial disease. A survey among physicians].

Authors:  L J Rüger; D Irnich; S Grasmueller; P M Lang
Journal:  Schmerz       Date:  2008-04       Impact factor: 1.107
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.